Myanmar ram ah COVID-19 kakuaisi chunh 1.5 million (ting 15) a phan. Minung ting 7 le cheu (750,000) an chunh hna lai. COVID-19 kakuaisi cu minung 1 voi 2 chunh asi.
India nih manlo tein a hlutmi si i January 22 ah a phan.
Yangon airport ah kakuaisi a phak lio (hmanthlak) cu Yangon um India Tanzung lutlai Kumar le Myanmar cozah nih an lak. Kumar nih, “hihi India nih Myanmar laksawng a pekmi si,” tiin thawngla pawl a chimh hna.
India nih Asia ram pawl; Maldives, Bhutan, Bangladesh le Nepal zong manlo in kakuaisi a kuat cang hna.
China nih Asia ram pawl “manlo in kakuaisi kan hlut hna lai” ati caah China nih pei Asia ram pawl a hip dih cang hna lai hi tiin India nih a hlut hmasa hna hi si. Myanmar zong China sermi kakuaisi chunh ting 3 kan hlut lai tiin China nih bia a tiam nain a hlu kho rih lo. India nih a tei deuh kan ti hnga maw.
Kakuaisi cu UK hrambunh sii company AstraZeneca nih a sermi si i India sii sehzung Serum Institute of India nih a chuahmi si. Mah sehzung hi vawlei cung kakuaisi sehzung nganbik asi.
Myanmar Ngandamnak Vuanci Zung biachimtu Khin Khin Gyi nih, “kakuaisi cu Yangon um tikhalternak khaan pawl ah kan chiah lai. Ngandamnak lei rianṭuan le tar pawl usape in chunh hmasa an si lai,” tiah a chim.
“Kan ram ah ngandamnak lei rianṭuan ting 1 le thong 10 (110,000) leng an um.
“Kakuaisi a phan cang tiin mipi daithlang hlah uh. Zawtnak a karhnak hnga lo ngandamnak zulhphung zul peng rih uh,” ati.
Myanmar ram ah COVID-19 zawtnak ngei ting 1 le thong 40 deng an hmuh cang hna. Mah chungah 3,000 leng an thi cang.
Nai hrawng cu mizaw thar hmuhmi an tlawm deuh nain, sii lei thiamsang pawl nih, “Myanmar cu minung tlawmtuk lawng an test hna caah hmuh rih lomi mizaw an tampi kho men,” an ti.
